Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontransmembrane receptor protein tyrosine kinase activator activity

AREG VEGFA

3.15e-0422242GO:0030297
GeneOntologyMolecularFunctionprotein tyrosine kinase activator activity

AREG VEGFA

8.51e-0436242GO:0030296
DomainTPR_8

SRP72 RPAP3

1.92e-0353232PF13181
DomainTPR_1

SRP72 RPAP3

5.44e-0390232PF00515
DomainTPR_1

SRP72 RPAP3

5.44e-0390232IPR001440
DomainTPR

SRP72 RPAP3

1.09e-02129232SM00028
DomainTPR_repeat

SRP72 RPAP3

1.15e-02133232IPR019734
DomainTPR-contain_dom

SRP72 RPAP3

1.45e-02150232IPR013026
DomainTPR

SRP72 RPAP3

1.74e-02165232PS50005
DomainTPR_REGION

SRP72 RPAP3

1.74e-02165232PS50293
Pubmed

A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.

NBPF10 NBPF19 NBPF12 NBPF20 NBPF1

4.68e-122128516079250
Pubmed

Interactome and Proteome Dynamics Uncover Immune Modulatory Associations of the Pathogen Sensing Factor cGAS.

MRPS5 SRP72 USP10 MACROH2A2 RRS1

1.01e-0622828530471916
Pubmed

Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarrays.

AREG VEGFA

1.87e-06328222395988
Pubmed

Human airway smooth muscle cells secrete amphiregulin via bradykinin/COX-2/PGE2, inducing COX-2, CXCL8, and VEGF expression in airway epithelial cells.

AREG VEGFA

3.75e-06428226047642
Pubmed

Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.

SCAF1 USP10 GTF2F1 RRS1

4.01e-0613428428695742
Pubmed

ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex.

MRPS5 SCAF1 SRP72 MACROH2A2 RRS1

6.13e-0633028533301849
Pubmed

Amphiregulin enhances VEGF-A production in human chondrosarcoma cells and promotes angiogenesis by inhibiting miR-206 via FAK/c-Src/PKCδ pathway.

AREG VEGFA

6.24e-06528227826039
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

MRPS5 SCAF1 SRP72 USP10 STRN3 GTF2F1 XPC RRS1

1.66e-05149728831527615
Pubmed

Lineage-specific gene duplication and loss in human and great ape evolution.

NBPF19 USP10 NBPF20

2.36e-056928315252450
Pubmed

MAP4K Interactome Reveals STRN4 as a Key STRIPAK Complex Component in Hippo Pathway Regulation.

MRPS5 USP10 STRN3 RPAP3

2.64e-0521628432640226
Pubmed

Evolutionary history and genome organization of DUF1220 protein domains.

NBPF12 NBPF1

2.80e-051028222973535
Pubmed

Implantation and decidualization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR.

AREG VEGFA

3.42e-051128210803598
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

NBPF10 MRPS5 SRP72 USP10 GTF2F1 RRS1

3.73e-0580728622681889
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

SCAF1 SRP72 USP10 XPC RRS1 DENR TFPI

8.32e-05137128736244648
Pubmed

An interactive association of common sequence variants in the neuropeptide Y gene with susceptibility to ischemic stroke.

TFPI VEGFA

9.49e-051828217702963
Pubmed

HACE1 mediated K27 ubiquitin linkage leads to YB-1 protein secretion.

SRP72 USP10

1.06e-041928226343856
Pubmed

Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.

AREG VEGFA

1.30e-042128219710174
Pubmed

EGFL7 is expressed in bone microenvironment and promotes angiogenesis via ERK, STAT3, and integrin signaling cascades.

AREG VEGFA

2.50e-042928224909139
Pubmed

Uterine Rbpj is required for embryonic-uterine orientation and decidual remodeling via Notch pathway-independent and -dependent mechanisms.

AREG VEGFA

2.50e-042928224971735
Pubmed

Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.

GTF2F1 MACROH2A2 RPAP3

2.67e-0415628337108203
Pubmed

Uterine RAC1 via Pak1-ERM signaling directs normal luminal epithelial integrity conducive to on-time embryo implantation in mice.

AREG VEGFA

3.05e-043228226184908
Pubmed

The histone acetyltransferase KAT6A is recruited to unmethylated CpG islands via a DNA binding winged helix domain.

MRPS5 SCAF1 GTF2F1 RRS1

3.32e-0441728436537216
Pubmed

Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?

NBPF10 NBPF12 NBPF1

3.44e-0417028323314748
Pubmed

BMPR2 is required for postimplantation uterine function and pregnancy maintenance.

AREG VEGFA

3.45e-043428223676498
Pubmed

CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system.

USP10 GTF2F1 RRS1 VEGFA

4.07e-0444028435156780
Pubmed

Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

MRPS5 USP10 GTF2F1 RRS1

4.10e-0444128431239290
Pubmed

Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly.

STRN3 RPAP3

4.32e-043828236674791
Pubmed

Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.

MRPS5 USP10 CCPG1 XPC RRS1

5.22e-0484728535850772
Pubmed

The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.

MRPS5 SRP72 MACROH2A2 RRS1

5.77e-0448328436912080
Pubmed

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.

NBPF10 COL5A3 NBPF12 NBPF1

7.23e-0451328425798074
Pubmed

Ggnbp2 Is Essential for Pregnancy Success via Regulation of Mouse Trophoblast Stem Cell Proliferation and Differentiation.

AREG VEGFA

7.78e-045128226764350
CytobandEnsembl 112 genes in cytogenetic band chr1q21

NBPF10 NBPF19 NBPF12 NBPF20

1.18e-04404294chr1q21
CytobandEnsembl 112 genes in cytogenetic band chr4q12

SRP72 LRRC66

1.30e-0384292chr4q12
CytobandEnsembl 112 genes in cytogenetic band chr2q37

ERFE SP140L

8.97e-03226292chr2q37
GeneFamilyNeuroblastoma breakpoint family

NBPF10 NBPF19 NBPF12 NBPF20 NBPF1

4.20e-1123215662
GeneFamilyTetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome

SRP72 RPAP3

7.78e-03115212769
CoexpressionLIU_SOX4_TARGETS_DN

SRP72 USP10 CCPG1 TFPI VEGFA

1.76e-05310285M17287
ToppCellControl-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

NBPF10 NBPF12 SLF1 NBPF1

2.25e-06144294984470ff6ddce4c743e2db78fa98dae055aaa273
ToppCellControl-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

NBPF10 NBPF12 SLF1 NBPF1

4.04e-06167294948504367ecf58144d9dd74d2ec531358fc4b309
ToppCellGlobus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

ERFE LRRC66 AREG

6.18e-065529321a72cc6f12889509dbfaa9929be48d00f5f6345
ToppCellGlobus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1-Excitatory_Neuron.Gad1Gad2.Drd1-Pdyn_(Striatum,_patch_dSPNs)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

ERFE LRRC66 AREG

6.18e-06552936575ee5274f1044e17f4a5204375acc82ef16182
ToppCellCOPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class

NBPF10 NBPF19 AREG VEGFA

6.60e-06189294d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCellSevere-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

NBPF10 NPAS3 NBPF1

5.10e-051112937021009545178fac1f19f3c429bfedb2f38b680d
ToppCellSevere-B_intermediate-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

NBPF10 NPAS3 NBPF1

7.43e-0512629342a0bdbe18ef85146cac4e86b2b27d0b3b20d8a2
ToppCelldroplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLF1 TFPI VEGFA

8.53e-051322934152529611eeacf0c547e2a134d5b98c45426b13
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

NBPF10 NPAS3 NBPF1

9.12e-051352937743a01dc9c4542e910e7c0fe046004692a680bf
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MACROH2A2 AREG VEGFA

9.73e-05138293c172880eda7b8b8b758dbbc77f93191238f3181c
ToppCellPBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MACROH2A2 AREG VEGFA

9.94e-05139293313f7e66ed94950129c7146a2afe2feb8951fe1e
ToppCell5'-Adult-Appendix-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NBPF10 NPAS3 NBPF19

1.37e-041552935fabe24a784f0be46040ffc886eabd8d5ce78121
ToppCellControl-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

NBPF10 SLF1 NBPF1

1.37e-041552930a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCellICU-NoSEP-Lymphocyte-T_NK-NK_CD56bright|ICU-NoSEP / Disease, Lineage and Cell Type

NBPF12 RRS1 AREG

1.71e-04167293f4f188a8efca8cdd0ecfb857fe4538c10847eadd
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

AREG TFPI VEGFA

1.71e-04167293ecdbfde870a2a44c44b9dd65a8737afc6fbf816c
ToppCellCOVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class

NBPF19 AREG VEGFA

1.74e-04168293ea465152ea31391b63c02425beafa9a4f51f6703
ToppCell368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells)

USP10 SLF1 NBPF1

1.83e-041712933b3143e4aa6520ee9c6b6f2482206ad3d8205d14
ToppCellControl-B_naive-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

NBPF10 SLF1 NBPF1

1.83e-04171293d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells)

USP10 SLF1 NBPF1

1.83e-04171293fd01076574dcc82bfd4a1538812500543b16794f
ToppCellCOVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class

NBPF19 AREG VEGFA

1.90e-04173293502f888b7684ed39f5c577eedcacf673ae81d39e
ToppCellCTRL-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class

NBPF10 AREG TFPI

1.93e-04174293ff4315e9fad198cc323fc987deb8652da137cf98
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ERFE MACROH2A2 NBPF12

2.17e-041812939275531e896e118cee043ed94fd31a0070d9581c
ToppCell390C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

ERFE MACROH2A2 NBPF12

2.20e-0418229321744c9c792e57d5d41b25986f419b2358c7057b
ToppCelldroplet-Marrow-BM-1m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

XPC RRS1 TFPI

2.31e-041852933f1aa91efae2d00320d126087cce1431ad5f26ea
ToppCellFetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NPAS3 UBE2QL1 TFPI

2.31e-04185293f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCelldroplet-Marrow-nan-21m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

XPC RRS1 TFPI

2.35e-04186293744bf39af2fb5a7454477174d7755a6d78cd279f
ToppCelldroplet-Marrow-nan-3m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

XPC RRS1 VEGFA

2.42e-04188293e079a3873cf442e98ff41a240c80b80995aace11
ToppCelldroplet-Marrow-nan-18m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

XPC RRS1 TFPI

2.42e-041882931b349618f77260564486586b7f5a47a77d12859c
ToppCellCOPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class

NBPF19 AREG VEGFA

2.46e-041892936294691231c7d38707323cf31578a107d3b2c622
ToppCellLV-01._Fibroblast_I|World / Chamber and Cluster_Paper

NPAS3 COL5A3 TFPI

2.50e-0419029312992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MACROH2A2 AREG VEGFA

2.54e-0419129392c5a26b90a55831039220341d863cf2940f3c9b
ToppCellPBMC-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MACROH2A2 AREG VEGFA

2.58e-041922936184163dbfca882824cb266bb9030d9f79e3acb0
ToppCellLV-01._Fibroblast_I|LV / Chamber and Cluster_Paper

NPAS3 COL5A3 TFPI

2.62e-04193293dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell343B-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

NBPF19 AREG VEGFA

2.62e-0419329324c06b0461894fe9f68bf26507d7a708468237c2
ToppCellControl-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class

AREG TFPI VEGFA

2.62e-041932932a6d531abd34df20941cf3dac4fdfb1621a1bde6
ToppCellControl-Myeloid-MoAM5,_CCL3L1|Control / Condition, Lineage and Cell class

NBPF19 AREG VEGFA

2.66e-04194293a1dd264822de83a0ffaf89ca4707c6a76809359e
ToppCellControl-Myeloid-Migratory_DC|Control / Condition, Lineage and Cell class

AREG TFPI VEGFA

2.66e-04194293374076e60dcee83eb1814aa6b55b77668909f40b
ToppCell356C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

NBPF19 AREG VEGFA

2.66e-041942933f9ac1de8605a7930f49a7ce0e32aea9997d7791
ToppCellControl-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class

NBPF19 AREG VEGFA

2.66e-0419429396400477d130b2403ed81c229e4e4182cc2cdc14
ToppCell356C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

NBPF19 AREG VEGFA

2.66e-04194293a41cde3088b43670210daab4f43a24aa83dbd45b
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NPAS3 TFPI VEGFA

2.66e-0419429308fad7591c20568de797cf8e206de2d0b1d78aab
ToppCell343B-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

NBPF19 AREG VEGFA

2.70e-04195293ff87a33f9a48765bfa9408f686985feefeff2adf
ToppCellControl-Myeloid-Migratory_DC|Myeloid / Condition, Lineage and Cell class

AREG TFPI VEGFA

2.70e-041952939f1ad04abc6a6c5e093ea24b60732871b1fad5a4
ToppCellCOVID-19_Severe-cDC|COVID-19_Severe / disease group, cell group and cell class

MACROH2A2 AREG VEGFA

2.70e-041952936419090b19de7b5d5140eaecf231860273da2c0d
ToppCell(3)_MNP-(3)_Monocyte|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4)

NBPF19 AREG VEGFA

2.74e-0419629383af2eb1c28dfe7678d972be1d6d358c4a94731d
ToppCellNon-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster

NPAS3 NBPF19 COL5A3

2.78e-041972939d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCellNon-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster

NPAS3 NBPF19 COL5A3

2.78e-0419729361749ccafeb938c310cff1de5ff924a1c794325a
ToppCellAT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

NBPF20 AREG TFPI

2.78e-04197293fd7bdfa6bf5966ebc11fdd13915769429540ddbf
ToppCell10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

USP10 CCPG1 VEGFA

2.82e-0419829382f6ac18c3a6487f03579b5c247844f1c115c2be
ToppCell10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

USP10 CCPG1 VEGFA

2.82e-04198293f870e398e996c1f28c8462d87b18f71b20c71011
ToppCellAT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

AREG TFPI VEGFA

2.82e-04198293893036558a9ad86b57f9e735df35812e9d18739e
ToppCellCOVID-19_Severe-cDC|World / disease group, cell group and cell class

MACROH2A2 AREG VEGFA

2.82e-04198293c452334249f047265ae89dcabe7de446d968cae6
ToppCell10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

USP10 CCPG1 VEGFA

2.86e-0419929386f2857ce60fbe59375411373ff49c684fd66ad0
ToppCellMacroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic

NBPF10 NBPF19 COL5A3

2.90e-0420029316f468217427921fa18c6d078ffa990eb019b257
ToppCellMacroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic

NBPF10 NBPF19 COL5A3

2.90e-04200293d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCellMacroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic

NBPF10 NBPF19 COL5A3

2.90e-04200293f861509b54185d89931db64da1b9d81986cc7938
ToppCellMacroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic

NBPF10 NBPF19 COL5A3

2.90e-042002930442894c39eec69850c090957a5dc7bcecd21e04
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Macroglial-Astrocyte|10w / Sample Type, Dataset, Time_group, and Cell type.

NBPF10 NPAS3 TFPI

2.90e-0420029375f5ea38fbd341b80a8058077a04447f0e0eea28
ToppCellMacroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic

NBPF10 NBPF19 COL5A3

2.90e-0420029301819446deeab9054f5cfe889d53bb49d137dbc0
ToppCellSepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class

NBPF12 RRS1 AREG

2.90e-04200293c2df917900872453ea17a39928e39d071a6d3339
ToppCellLung_Parenchyma|World / Location, Disease Group, Cell group, Cell class (2021.03.09)

AREG TFPI VEGFA

2.95e-0420129391ec5eebe93a3c7b1a33c27e5da949b123b676a8
DrugDalteparin

TFPI VEGFA

8.11e-064272DB06779
Drug2,3-bis(3'-hydroxybenzyl)butyrolactone

NPAS3 STRN3 CCPG1 SLF1 UBE2QL1 NBPF1 TFPI VEGFA

1.06e-05961278ctd:C029497
DrugPesticides

NBPF10 NBPF12 NBPF20 NBPF1

2.82e-05150274ctd:D010575
Diseasegraft-versus-host disease (is_marker_for)

TFPI VEGFA

4.52e-0512252DOID:0081267 (is_marker_for)
DiseaseSquamous cell carcinoma

XPC AREG VEGFA

1.56e-04124253C0007137
DiseaseHead Neoplasms

AREG VEGFA

1.88e-0424252C0018675
DiseaseUpper Aerodigestive Tract Neoplasms

AREG VEGFA

1.88e-0424252C0887900
DiseaseCancer of Head

AREG VEGFA

1.88e-0424252C0751177
DiseaseCancer of Neck

AREG VEGFA

2.04e-0425252C0746787
DiseaseNeck Neoplasms

AREG VEGFA

2.04e-0425252C0027533
DiseaseNon-Small Cell Lung Carcinoma

XPC AREG VEGFA

3.06e-04156253C0007131
Diseasemyocardial infarction (is_marker_for)

TFPI VEGFA

3.58e-0433252DOID:5844 (is_marker_for)
DiseaseHead and Neck Neoplasms

AREG VEGFA

3.58e-0433252C0018671
Diseaseductal carcinoma in situ (is_marker_for)

AREG VEGFA

5.01e-0439252DOID:0060074 (is_marker_for)
DiseaseMalignant Head and Neck Neoplasm

AREG VEGFA

6.38e-0444252C0278996
DiseaseAdenocarcinoma of lung (disorder)

MRPS5 XPC RRS1

6.89e-04206253C0152013
Diseasepre-eclampsia (is_marker_for)

TFPI VEGFA

1.11e-0358252DOID:10591 (is_marker_for)
DiseaseAsthma

AREG VEGFA

2.09e-0380252C0004096
Diseasesusceptibility to pneumonia measurement

RPAP3 AREG

3.05e-0397252EFO_0008410
Diseasediffuse plaque measurement

NPAS3 ERFE SCAF1 SP140L

3.56e-03758254EFO_0010699
Diseaseurinary bladder cancer (is_marker_for)

AREG VEGFA

3.70e-03107252DOID:11054 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
RKKKGGKNGKNRRNR

AREG

126

P15514
GRKATSGKKGGKKSK

MACROH2A2

136

Q9P0M6
KDSKGKGKGKDKRRG

IQCG

426

Q9H095
KGVNGKKRSRGKAKK

ERFE

91

Q4G0M1
KGKGKKRRGRRSTKK

NBPF1

1101

Q3BBV0
GKKAKAGSGLRKKQR

LRRC66

336

Q68CR7
GKKKGGRGSHRAKNK

CCPG1

466

Q9ULG6
QKRGGRGQIKQKKKT

DENR

96

O43583
RKGKGKGRKKGRGRK

COL5A3

246

P25940
KGRKKGRGRKGKGRK

COL5A3

251

P25940
TGAGAKKGRGKRTKK

MRPS5

106

P82675
RVNGKSGRKFKGIKK

GTF2F1

101

P35269
KKERKGKKGVKRANR

STRN3

356

Q13033
KKGKGKKRRGRRSKK

NBPF10

1561

Q6P3W6
KKGKGKKRRGRRSKK

NBPF10

2781

Q6P3W6
KGKGKKRRGRRSKKK

NBPF12

1101

Q5TAG4
KKGKGKKRRGRRSKK

NBPF19

1046

A0A087WUL8
KKGKGKKRRGRRSKK

NBPF19

2266

A0A087WUL8
KKGKGKKRRGRRSKK

NBPF19

3486

A0A087WUL8
KKGKGKKRRGRRSKK

NBPF20

946

P0DPF2
KKGKGKKRRGRRSKK

NBPF20

2166

P0DPF2
KKGKGKKRRGRRSKK

NBPF20

3386

P0DPF2
KKGKGKKRRGRRSKK

NBPF20

4531

P0DPF2
KHQKRKKRRKRQKGG

NPAS3

596

Q8IXF0
YRGRKKGKKKDQIGK

SRP72

586

O76094
GKPKRKRRKKKGHGW

SP140L

206

Q9H930
KGQGRICRKAGKSKK

UBE2QL1

116

A1L167
IRNGNFRKKKKGKAK

RPAP3

56

Q9H6T3
RGKHRDGGGSKKKKK

SCAF1

631

Q9H7N4
DGGGSKKKKKRSRSR

SCAF1

636

Q9H7N4
AKRRKMSQKGKRKGG

RRS1

301

Q15050
SKGGLIKTKRKRKKQ

TFPI

276

P10646
RRKRKKGKESNCKKG

SLF1

311

Q9BQI6
SGGLGQRERKKKKKR

USP10

141

Q14694
AKGKRNKGGRKKRSK

XPC

381

Q01831
KKSVRGKGKGQKRKR

VEGFA

141

P15692
GKGKGQKRKRKKSRY

VEGFA

146

P15692
GVGKRGKRKNKKNRR

PNMA8C

181

A0A1B0GUJ8